25 XP   0   0   10

Ortivus AB ser. B
Buy, Hold or Sell?

Let's analyse Ortivus together

PenkeI guess you are interested in Ortivus AB ser. B. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Ortivus AB ser. B. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Ortivus AB ser. B

I send you an email if I find something interesting about Ortivus AB ser. B.

Quick analysis of Ortivus (30 sec.)










What can you expect buying and holding a share of Ortivus? (30 sec.)

How much money do you get?

How much money do you get?
kr0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
kr0.93
Expected worth in 1 year
kr1.07
How sure are you?
55.0%

+ What do you gain per year?

Total Gains per Share
kr0.13
Return On Investment
4.6%

For what price can you sell your share?

Current Price per Share
kr2.91
Expected price per share
kr2.15 - kr3.8
How sure are you?
50%

1. Valuation of Ortivus (5 min.)




Live pricePrice per Share (EOD)

kr2.91

Intrinsic Value Per Share

kr2.31 - kr11.81

Total Value Per Share

kr3.25 - kr12.75

2. Growth of Ortivus (5 min.)




Is Ortivus growing?

Current yearPrevious yearGrowGrow %
How rich?$3.8m$3.2m-$184.8k-6.1%

How much money is Ortivus making?

Current yearPrevious yearGrowGrow %
Making money-$435k$138.4k-$573.4k-131.8%
Net Profit Margin-25.8%5.7%--

How much money comes from the company's main activities?

3. Financial Health of Ortivus (5 min.)




4. Comparing to competitors in the Medical Instruments & Supplies industry (5 min.)




  Industry Rankings (Medical Instruments & Supplies)  


Richest
#152 / 173

Most Revenue
#143 / 173

Most Profit
#116 / 173

Most Efficient
#132 / 173

What can you expect buying and holding a share of Ortivus? (5 min.)

Welcome investor! Ortivus's management wants to use your money to grow the business. In return you get a share of Ortivus.

What can you expect buying and holding a share of Ortivus?

First you should know what it really means to hold a share of Ortivus. And how you can make/lose money.

Speculation

The Price per Share of Ortivus is kr2.91. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Ortivus.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Ortivus, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is kr0.93. Based on the TTM, the Book Value Change Per Share is kr0.03 per quarter. Based on the YOY, the Book Value Change Per Share is kr0.03 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is kr0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Ortivus.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 kr% of Price per Sharekr% of Price per Sharekr% of Price per Sharekr% of Price per Sharekr% of Price per Share
Usd Eps-0.01-0.2%-0.01-0.3%0.000.1%0.000.0%0.00-0.1%
Usd Book Value Change Per Share0.041.5%0.000.1%0.000.1%0.000.1%0.000.0%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.041.5%0.000.1%0.000.1%0.000.1%0.000.0%
Usd Price Per Share0.35-0.39-0.54-0.43-0.38-
Price to Earnings Ratio-14.79-50.84-149.16-49.19-30.56-
Price-to-Total Gains Ratio7.84-129.36-922.58-249.87--2,113.70-
Price to Book Ratio3.97-5.84-7.39-10.21-13.66-
Price-to-Total Gains Ratio7.84-129.36-922.58-249.87--2,113.70-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.27354
Number of shares3655
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.000.00
Usd Total Gains Per Share0.000.00
Gains per Quarter (3655 shares)11.5115.16
Gains per Year (3655 shares)46.0360.64
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10463606151
2092820121112
301381280182173
401841740243234
502302200303295
602762660364356
703223120424417
803683580485478
904144040546539
1004604500606600

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.03.00.025.0%9.03.00.075.0%13.07.00.065.0%19.021.00.047.5%21.035.00.037.5%
Book Value Change Per Share2.02.00.050.0%10.02.00.083.3%16.04.00.080.0%22.018.00.055.0%25.028.03.044.6%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%0.00.040.00.0%0.00.056.00.0%
Total Gains per Share2.02.00.050.0%10.02.00.083.3%16.04.00.080.0%22.018.00.055.0%25.028.03.044.6%

Fundamentals of Ortivus

About Ortivus AB ser. B

Ortivus AB (publ) develops and commercializes medical technology solutions for healthcare industry in Sweden and internationally. The company offers MobiMed Monitor that monitors and measures the patient's vital parameters, such as ECG, blood pressure, and blood oxygenation; MobiMed ePR, an electronic patient record system for documentation of treatment and events; MobiMed Life, which is designed for advanced monitoring and resuscitation; and MobiMed Cloud that supports multiplatform data sharing on Windows, Webb, IOS, and Android. It also provides support, implementation, training, and consulting services. The company was incorporated in 1985 and is headquartered in Danderyd, Sweden.

Fundamental data was last updated by Penke on 2024-03-12 05:17:04.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is just able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is overpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Ortivus AB ser. B.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Ortivus earns for each kr1 of revenue.

  • Above 10% is considered healthy but always compare Ortivus to the Medical Instruments & Supplies industry mean.
  • A Net Profit Margin of -14.3% means that kr-0.14 for each kr1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Ortivus AB ser. B:

  • The MRQ is -14.3%. The company is making a huge loss. -2
  • The TTM is -25.8%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-14.3%TTM-25.8%+11.5%
TTM-25.8%YOY5.7%-31.6%
TTM-25.8%5Y-7.0%-18.8%
5Y-7.0%10Y-10.5%+3.5%
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ-14.3%6.2%-20.5%
TTM-25.8%7.4%-33.2%
YOY5.7%8.0%-2.3%
5Y-7.0%7.1%-14.1%
10Y-10.5%7.7%-18.2%
1.1.2. Return on Assets

Shows how efficient Ortivus is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Ortivus to the Medical Instruments & Supplies industry mean.
  • -3.8% Return on Assets means that Ortivus generated kr-0.04 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Ortivus AB ser. B:

  • The MRQ is -3.8%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -6.3%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-3.8%TTM-6.3%+2.5%
TTM-6.3%YOY1.9%-8.3%
TTM-6.3%5Y-1.8%-4.5%
5Y-1.8%10Y-3.1%+1.3%
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ-3.8%1.2%-5.0%
TTM-6.3%1.2%-7.5%
YOY1.9%1.7%+0.2%
5Y-1.8%1.6%-3.4%
10Y-3.1%1.6%-4.7%
1.1.3. Return on Equity

Shows how efficient Ortivus is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Ortivus to the Medical Instruments & Supplies industry mean.
  • -16.1% Return on Equity means Ortivus generated kr-0.16 for each kr1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Ortivus AB ser. B:

  • The MRQ is -16.1%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -21.2%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-16.1%TTM-21.2%+5.1%
TTM-21.2%YOY4.4%-25.6%
TTM-21.2%5Y-9.0%-12.2%
5Y-9.0%10Y-18.9%+9.9%
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ-16.1%2.3%-18.4%
TTM-21.2%2.6%-23.8%
YOY4.4%3.1%+1.3%
5Y-9.0%3.2%-12.2%
10Y-18.9%3.0%-21.9%

1.2. Operating Efficiency of Ortivus AB ser. B.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Ortivus is operating .

  • Measures how much profit Ortivus makes for each kr1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Ortivus to the Medical Instruments & Supplies industry mean.
  • An Operating Margin of -9.8% means the company generated kr-0.10  for each kr1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Ortivus AB ser. B:

  • The MRQ is -9.8%. The company is operating very inefficient. -2
  • The TTM is -30.2%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-9.8%TTM-30.2%+20.4%
TTM-30.2%YOY6.1%-36.3%
TTM-30.2%5Y-8.2%-22.0%
5Y-8.2%10Y-8.4%+0.1%
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ-9.8%7.9%-17.7%
TTM-30.2%6.4%-36.6%
YOY6.1%10.7%-4.6%
5Y-8.2%10.0%-18.2%
10Y-8.4%8.4%-16.8%
1.2.2. Operating Ratio

Measures how efficient Ortivus is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Medical Instruments & Supplies industry mean).
  • An Operation Ratio of 1.10 means that the operating costs are kr1.10 for each kr1 in net sales.

Let's take a look of the Operating Ratio trends of Ortivus AB ser. B:

  • The MRQ is 1.098. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.243. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.098TTM1.243-0.145
TTM1.243YOY0.944+0.299
TTM1.2435Y1.066+0.177
5Y1.06610Y1.092-0.026
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ1.0981.099-0.001
TTM1.2431.149+0.094
YOY0.9441.109-0.165
5Y1.0661.101-0.035
10Y1.0921.055+0.037

1.3. Liquidity of Ortivus AB ser. B.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Ortivus is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Medical Instruments & Supplies industry mean).
  • A Current Ratio of 1.94 means the company has kr1.94 in assets for each kr1 in short-term debts.

Let's take a look of the Current Ratio trends of Ortivus AB ser. B:

  • The MRQ is 1.936. The company is able to pay all its short-term debts. +1
  • The TTM is 1.534. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ1.936TTM1.534+0.402
TTM1.534YOY1.892-0.359
TTM1.5345Y1.383+0.151
5Y1.38310Y1.057+0.326
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ1.9362.385-0.449
TTM1.5342.589-1.055
YOY1.8922.582-0.690
5Y1.3832.635-1.252
10Y1.0572.614-1.557
1.3.2. Quick Ratio

Measures if Ortivus is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Ortivus to the Medical Instruments & Supplies industry mean.
  • A Quick Ratio of 0.91 means the company can pay off kr0.91 for each kr1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Ortivus AB ser. B:

  • The MRQ is 0.906. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.720. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.906TTM0.720+0.185
TTM0.720YOY1.040-0.320
TTM0.7205Y0.902-0.181
5Y0.90210Y0.591+0.311
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ0.9061.165-0.259
TTM0.7201.172-0.452
YOY1.0401.283-0.243
5Y0.9021.392-0.490
10Y0.5911.477-0.886

1.4. Solvency of Ortivus AB ser. B.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Ortivus assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Ortivus to Medical Instruments & Supplies industry mean.
  • A Debt to Asset Ratio of 0.43 means that Ortivus assets are financed with 43.1% credit (debt) and the remaining percentage (100% - 43.1%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Ortivus AB ser. B:

  • The MRQ is 0.431. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.582. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.431TTM0.582-0.151
TTM0.582YOY0.551+0.031
TTM0.5825Y0.649-0.067
5Y0.64910Y0.701-0.053
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ0.4310.353+0.078
TTM0.5820.355+0.227
YOY0.5510.358+0.193
5Y0.6490.362+0.287
10Y0.7010.369+0.332
1.4.2. Debt to Equity Ratio

Measures if Ortivus is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Ortivus to the Medical Instruments & Supplies industry mean.
  • A Debt to Equity ratio of 181.1% means that company has kr1.81 debt for each kr1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Ortivus AB ser. B:

  • The MRQ is 1.811. The company is just able to pay all its debts with equity.
  • The TTM is 1.803. The company is just able to pay all its debts with equity.
Trends
Current periodCompared to+/- 
MRQ1.811TTM1.803+0.008
TTM1.803YOY1.256+0.548
TTM1.8035Y2.235-0.432
5Y2.23510Y3.646-1.411
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ1.8110.541+1.270
TTM1.8030.545+1.258
YOY1.2560.529+0.727
5Y2.2350.640+1.595
10Y3.6460.665+2.981

2. Market Valuation of Ortivus AB ser. B

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every kr1 in earnings Ortivus generates.

  • Above 15 is considered overpriced but always compare Ortivus to the Medical Instruments & Supplies industry mean.
  • A PE ratio of -14.79 means the investor is paying kr-14.79 for every kr1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Ortivus AB ser. B:

  • The EOD is -11.603. Based on the earnings, the company is expensive. -2
  • The MRQ is -14.793. Based on the earnings, the company is expensive. -2
  • The TTM is 50.838. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-11.603MRQ-14.793+3.190
MRQ-14.793TTM50.838-65.630
TTM50.838YOY149.162-98.325
TTM50.8385Y49.186+1.652
5Y49.18610Y30.555+18.630
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
EOD-11.60317.153-28.756
MRQ-14.79318.041-32.834
TTM50.83819.435+31.403
YOY149.16220.661+128.501
5Y49.18621.526+27.660
10Y30.55527.509+3.046
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Ortivus AB ser. B:

  • The EOD is 35.854. Based on how much money comes from the company's main activities, the company is fair priced.
  • The MRQ is 45.711. Based on how much money comes from the company's main activities, the company is fair priced.
  • The TTM is -5.556. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD35.854MRQ45.711-9.857
MRQ45.711TTM-5.556+51.267
TTM-5.556YOY6.339-11.894
TTM-5.5565Y-3.769-1.787
5Y-3.76910Y-2.056-1.713
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
EOD35.85410.417+25.437
MRQ45.71110.581+35.130
TTM-5.5561.298-6.854
YOY6.3394.650+1.689
5Y-3.7694.114-7.883
10Y-2.0560.108-2.164
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Ortivus is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Medical Instruments & Supplies industry mean).
  • A PB ratio of 3.97 means the investor is paying kr3.97 for each kr1 in book value.

Let's take a look of the Price to Book Ratio trends of Ortivus AB ser. B:

  • The EOD is 3.117. Based on the equity, the company is fair priced.
  • The MRQ is 3.973. Based on the equity, the company is fair priced.
  • The TTM is 5.845. Based on the equity, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD3.117MRQ3.973-0.857
MRQ3.973TTM5.845-1.871
TTM5.845YOY7.391-1.546
TTM5.8455Y10.211-4.366
5Y10.21110Y13.663-3.453
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
EOD3.1172.531+0.586
MRQ3.9732.733+1.240
TTM5.8452.706+3.139
YOY7.3913.244+4.147
5Y10.2113.824+6.387
10Y13.6634.219+9.444
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Ortivus AB ser. B compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.4730.033+1314%0.027+1644%0.044+973%0.013+3475%
Book Value Per Share--0.9340.729+28%0.773+21%0.535+75%0.419+123%
Current Ratio--1.9361.534+26%1.892+2%1.383+40%1.057+83%
Debt To Asset Ratio--0.4310.582-26%0.551-22%0.649-34%0.701-39%
Debt To Equity Ratio--1.8111.803+0%1.256+44%2.235-19%3.646-50%
Dividend Per Share----0%-0%-0%-0%
Eps---0.063-0.103+64%0.033-289%-0.009-85%-0.027-57%
Free Cash Flow Per Share--0.020-0.002+109%-0.044+318%0.006+256%-0.008+139%
Free Cash Flow To Equity Per Share--0.0540.025+116%-0.047+188%0.018+204%0.006+737%
Gross Profit Margin--1.00042.980-98%-12.082+1308%6.056-83%3.729-73%
Intrinsic Value_10Y_max--11.814--------
Intrinsic Value_10Y_min--2.312--------
Intrinsic Value_1Y_max--0.144--------
Intrinsic Value_1Y_min---0.001--------
Intrinsic Value_3Y_max--1.226--------
Intrinsic Value_3Y_min--0.198--------
Intrinsic Value_5Y_max--3.263--------
Intrinsic Value_5Y_min--0.616--------
Market Cap123966000.000-33%164376002.000182433330.500-10%252771435.000-35%200211804.600-18%175955202.300-7%
Net Profit Margin---0.143-0.258+81%0.057-349%-0.070-51%-0.105-27%
Operating Margin---0.098-0.302+208%0.061-261%-0.082-16%-0.084-15%
Operating Ratio--1.0981.243-12%0.944+16%1.066+3%1.092+1%
Pb Ratio3.117-27%3.9735.845-32%7.391-46%10.211-61%13.663-71%
Pe Ratio-11.603+22%-14.79350.838-129%149.162-110%49.186-130%30.555-148%
Price Per Share2.910-27%3.7104.118-10%5.705-35%4.549-18%4.055-9%
Price To Free Cash Flow Ratio35.854-27%45.711-5.556+112%6.339+621%-3.769+108%-2.056+104%
Price To Total Gains Ratio6.146-27%7.836129.362-94%922.577-99%249.871-97%-2113.697+27075%
Quick Ratio--0.9060.720+26%1.040-13%0.902+0%0.591+53%
Return On Assets---0.038-0.063+66%0.019-300%-0.018-53%-0.031-19%
Return On Equity---0.161-0.212+32%0.044-467%-0.090-44%-0.189+18%
Total Gains Per Share--0.4730.033+1314%0.027+1644%0.044+973%0.013+3475%
Usd Book Value--3888780.0003034672.500+28%3219476.500+21%2215415.500+76%1713396.750+127%
Usd Book Value Change Per Share--0.0450.003+1314%0.003+1644%0.004+973%0.001+3475%
Usd Book Value Per Share--0.0880.068+28%0.073+21%0.050+75%0.039+123%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.006-0.010+64%0.003-289%-0.001-85%-0.003-57%
Usd Free Cash Flow--84506.000-7778.500+109%-184522.000+318%21934.900+285%-32145.650+138%
Usd Free Cash Flow Per Share--0.0020.000+109%-0.004+318%0.001+256%-0.001+139%
Usd Free Cash Flow To Equity Per Share--0.0050.002+116%-0.004+188%0.002+204%0.001+737%
Usd Market Cap11652804.000-33%15451344.18817148733.067-10%23760514.890-35%18819909.632-18%16539789.016-7%
Usd Price Per Share0.274-27%0.3490.387-10%0.536-35%0.428-18%0.381-9%
Usd Profit---261132.000-435008.500+67%138462.000-289%-37990.100-85%-107738.100-59%
Usd Revenue--1824352.0001989933.000-8%2455961.500-26%2076883.000-12%1807504.850+1%
Usd Total Gains Per Share--0.0450.003+1314%0.003+1644%0.004+973%0.001+3475%
 EOD+3 -5MRQTTM+26 -8YOY+18 -165Y+19 -1510Y+22 -12

3.2. Fundamental Score

Let's check the fundamental score of Ortivus AB ser. B based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-11.603
Price to Book Ratio (EOD)Between0-13.117
Net Profit Margin (MRQ)Greater than0-0.143
Operating Margin (MRQ)Greater than0-0.098
Quick Ratio (MRQ)Greater than10.906
Current Ratio (MRQ)Greater than11.936
Debt to Asset Ratio (MRQ)Less than10.431
Debt to Equity Ratio (MRQ)Less than11.811
Return on Equity (MRQ)Greater than0.15-0.161
Return on Assets (MRQ)Greater than0.05-0.038
Total2/10 (20.0%)

3.3. Technical Score

Let's check the technical score of Ortivus AB ser. B based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5042.265
Ma 20Greater thanMa 503.052
Ma 50Greater thanMa 1003.287
Ma 100Greater thanMa 2003.304
OpenGreater thanClose3.010
Total1/5 (20.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2022-12-312023-03-312023-06-302023-09-302023-12-31
Other Current Liabilities  24,883-4,77520,108-17,9412,167-3641,803-6,529-4,726



Latest Balance Sheet

Balance Sheet of 2023-12-31. All numbers in thousands.

Summary
Total Assets72,706
Total Liabilities31,336
Total Stockholder Equity17,305
 As reported
Total Liabilities 31,336
Total Stockholder Equity+ 17,305
Total Assets = 72,706

Assets

Total Assets72,706
Total Current Assets39,175
Long-term Assets33,531
Total Current Assets
Cash And Cash Equivalents 1,289
Net Receivables 17,039
Inventory 12,767
Other Current Assets 8,080
Total Current Assets  (as reported)39,175
Total Current Assets  (calculated)39,175
+/-0
Long-term Assets
Property Plant Equipment 5,791
Long-term Assets Other 23,740
Long-term Assets  (as reported)33,531
Long-term Assets  (calculated)29,531
+/- 4,000

Liabilities & Shareholders' Equity

Total Current Liabilities20,236
Long-term Liabilities11,100
Total Stockholder Equity17,305
Total Current Liabilities
Short-term Debt 11,207
Accounts payable 9,029
Other Current Liabilities -4,726
Total Current Liabilities  (as reported)20,236
Total Current Liabilities  (calculated)15,510
+/- 4,726
Long-term Liabilities
Long-term Liabilities  (as reported)11,100
Long-term Liabilities  (calculated)0
+/- 11,100
Total Stockholder Equity
Total Stockholder Equity (as reported)17,305
Total Stockholder Equity (calculated)0
+/- 17,305
Other
Cash and Short Term Investments 1,289
Common Stock Shares Outstanding 44,306
Current Deferred Revenue4,726
Liabilities and Stockholders Equity 72,706
Net Debt 22,037
Net Working Capital 18,939
Short Long Term Debt Total 23,326



Balance Sheet

All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-31
> Total Assets 
0
0
0
83,508
75,462
67,413
58,278
51,033
63,808
48,569
46,488
53,192
46,349
39,539
36,096
36,780
40,298
57,231
76,221
82,804
85,021
91,197
74,795
66,047
67,232
61,185
61,068
47,247
42,742
46,418
37,721
34,540
33,979
31,295
30,479
27,697
32,848
36,521
29,880
34,940
50,479
71,820
62,090
66,550
77,659
68,682
73,433
72,459
72,634
80,184
66,145
89,750
89,054
75,498
71,847
72,706
72,70671,84775,49889,05489,75066,14580,18472,63472,45973,43368,68277,65966,55062,09071,82050,47934,94029,88036,52132,84827,69730,47931,29533,97934,54037,72146,41842,74247,24761,06861,18567,23266,04774,79591,19785,02182,80476,22157,23140,29836,78036,09639,53946,34953,19246,48848,56963,80851,03358,27867,41375,46283,508000
   > Total Current Assets 
0
0
0
63,850
56,570
48,556
39,014
40,576
53,678
38,807
37,230
43,763
36,216
28,668
24,025
25,148
26,721
39,786
50,060
43,775
44,431
42,929
26,550
22,521
28,634
27,109
27,092
17,522
17,014
21,524
15,510
14,487
16,254
15,798
16,087
14,758
18,100
23,335
18,404
25,183
40,940
62,177
51,774
56,284
65,084
53,996
58,355
55,372
55,116
61,785
48,063
66,250
59,359
44,081
39,272
39,175
39,17539,27244,08159,35966,25048,06361,78555,11655,37258,35553,99665,08456,28451,77462,17740,94025,18318,40423,33518,10014,75816,08715,79816,25414,48715,51021,52417,01417,52227,09227,10928,63422,52126,55042,92944,43143,77550,06039,78626,72125,14824,02528,66836,21643,76337,23038,80753,67840,57639,01448,55656,57063,850000
       Cash And Cash Equivalents 
0
0
0
28,135
23,329
10,508
20,589
13,676
12,357
12,174
15,978
20,444
16,760
13,731
10,038
7,895
4,414
4,125
5,912
11,730
3,462
4,782
2,308
1,223
1,994
1,320
3,117
2,038
1,611
6,135
2,158
1,702
766
1,278
2,619
3,359
7,540
11,549
6,180
8,678
22,149
33,203
28,485
22,127
26,600
19,261
4,887
22,112
27,696
18,282
8,345
7,597
8,220
4,019
1,165
1,289
1,2891,1654,0198,2207,5978,34518,28227,69622,1124,88719,26126,60022,12728,48533,20322,1498,6786,18011,5497,5403,3592,6191,2787661,7022,1586,1351,6112,0383,1171,3201,9941,2232,3084,7823,46211,7305,9124,1254,4147,89510,03813,73116,76020,44415,97812,17412,35713,67620,58910,50823,32928,135000
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
813
0
0
0
79
0
0
0
60
0
0
0
11
0
565
598
1,497
-200
631
0
0
0
0
0
0
0
0
0
0
0000000000631-2001,4975985650110006000079000813000000000000000000000000000
       Net Receivables 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
4,981
11,847
12,087
9,981
7,059
11,849
11,486
9,550
5,366
7,009
6,995
7,720
8,882
10,405
10,259
11,809
22,689
24,891
21,818
42,673
23,156
15,930
24,542
15,966
3,001
27,990
16,132
10,460
17,039
17,03910,46016,13227,9903,00115,96624,54215,93023,15642,67321,81824,89122,68911,80910,25910,4058,8827,7206,9957,0095,3669,55011,48611,8497,0599,98112,08711,8474,981000000000000000000000000000
       Other Current Assets 
0
0
0
29,416
27,517
30,164
9,085
17,684
28,133
16,994
14,018
15,450
13,134
8,999
8,507
11,210
15,855
26,392
35,327
21,617
29,120
32,699
19,848
17,385
22,843
21,032
18,928
11,664
11,847
11,904
9,982
9,348
11,849
11,486
9,550
7,397
7,009
6,995
7,720
12,480
15,647
16,962
18,865
29,171
34,205
28,364
48,650
28,483
22,148
32,583
25,806
41,255
6,018
11,232
10,655
8,080
8,08010,65511,2326,01841,25525,80632,58322,14828,48348,65028,36434,20529,17118,86516,96215,64712,4807,7206,9957,0097,3979,55011,48611,8499,3489,98211,90411,84711,66418,92821,03222,84317,38519,84832,69929,12021,61735,32726,39215,85511,2108,5078,99913,13415,45014,01816,99428,13317,6849,08530,16427,51729,416000
   > Long-term Assets 
0
0
0
19,658
18,892
18,857
19,264
10,457
10,130
9,762
9,258
9,429
10,133
10,872
12,071
11,632
13,577
17,445
26,161
39,030
40,590
48,268
48,244
43,526
38,597
34,076
33,976
29,725
25,728
24,712
22,211
20,053
17,725
15,497
14,392
12,939
14,748
13,187
11,476
9,757
9,539
9,643
10,316
10,266
12,575
14,686
15,078
17,087
17,518
18,399
18,082
23,500
29,695
31,417
32,575
33,531
33,53132,57531,41729,69523,50018,08218,39917,51817,08715,07814,68612,57510,26610,3169,6439,5399,75711,47613,18714,74812,93914,39215,49717,72520,05322,21124,71225,72829,72533,97634,07638,59743,52648,24448,26840,59039,03026,16117,44513,57711,63212,07110,87210,1339,4299,2589,76210,13010,45719,26418,85718,89219,658000
       Property Plant Equipment 
0
0
0
2,015
1,807
1,539
1,530
1,358
1,481
1,651
1,599
1,586
1,642
1,577
1,490
1,594
1,807
1,952
8,152
18,572
17,564
22,867
21,515
18,644
15,505
12,740
14,394
11,899
9,399
9,880
8,876
8,215
7,334
6,433
5,413
4,353
6,303
4,998
3,692
2,588
2,687
3,081
3,386
3,003
4,524
5,508
5,050
5,451
4,981
4,834
3,726
8,452
7,593
7,094
6,528
5,791
5,7916,5287,0947,5938,4523,7264,8344,9815,4515,0505,5084,5243,0033,3863,0812,6872,5883,6924,9986,3034,3535,4136,4337,3348,2158,8769,8809,39911,89914,39412,74015,50518,64421,51522,86717,56418,5728,1521,9521,8071,5941,4901,5771,6421,5861,5991,6511,4811,3581,5301,5391,8072,015000
       Intangible Assets 
0
0
0
0
17,055
17,289
17,711
9,084
8,622
0
0
7,784
0
0
0
10,010
0
0
0
20,458
0
0
0
24,882
0
0
0
17,826
16,329
14,832
13,335
11,838
10,391
9,064
8,979
8,586
8,445
8,188
7,783
7,169
6,852
6,562
6,930
7,263
8,051
9,178
10,028
11,635
12,537
13,565
14,356
15,047
18,102
20,323
0
0
0020,32318,10215,04714,35613,56512,53711,63510,0289,1788,0517,2636,9306,5626,8527,1697,7838,1888,4458,5868,9799,06410,39111,83813,33514,83216,32917,82600024,88200020,45800010,0100007,784008,6229,08417,71117,28917,0550000
       Other Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
96,489
0
77,195
0
0
17,729
0
49,606
0
11,775
0
0
0
8,547
0
0
1
7,169
6,852
6,562
6,931
7,263
8,051
9,178
10,028
11,635
12,537
13,565
14,356
15,047
0
24,323
0
0
0024,323015,04714,35613,56512,53711,63510,0289,1788,0517,2636,9316,5626,8527,1691008,54700011,775049,606017,7290077,195096,4890000000000000000000000
> Total Liabilities 
0
0
0
16,560
13,451
17,280
17,096
22,002
37,845
19,151
13,402
22,005
17,171
13,174
12,086
19,569
20,866
36,212
53,149
63,457
65,421
71,599
60,300
53,684
58,329
55,532
56,869
42,025
40,055
24,830
20,089
18,985
22,131
24,095
24,333
25,516
28,290
22,632
19,333
26,186
40,622
55,355
44,440
46,872
55,779
43,794
45,812
43,015
41,480
45,100
30,819
54,315
53,249
43,931
51,454
31,336
31,33651,45443,93153,24954,31530,81945,10041,48043,01545,81243,79455,77946,87244,44055,35540,62226,18619,33322,63228,29025,51624,33324,09522,13118,98520,08924,83040,05542,02556,86955,53258,32953,68460,30071,59965,42163,45753,14936,21220,86619,56912,08613,17417,17122,00513,40219,15137,84522,00217,09617,28013,45116,560000
   > Total Current Liabilities 
0
0
0
16,126
13,037
16,878
16,321
21,466
37,304
18,762
12,575
21,525
16,682
12,674
11,560
19,166
20,329
36,212
51,714
59,598
64,906
61,525
51,416
46,045
47,916
45,676
46,916
36,399
36,609
22,389
18,184
17,415
20,941
23,143
23,379
24,921
25,810
20,767
18,076
25,420
39,920
54,925
44,284
46,732
54,207
42,076
44,391
30,925
30,341
33,774
20,094
43,242
37,654
29,925
34,174
20,236
20,23634,17429,92537,65443,24220,09433,77430,34130,92544,39142,07654,20746,73244,28454,92539,92025,42018,07620,76725,81024,92123,37923,14320,94117,41518,18422,38936,60936,39946,91645,67647,91646,04551,41661,52564,90659,59851,71436,21220,32919,16611,56012,67416,68221,52512,57518,76237,30421,46616,32116,87813,03716,126000
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,649
0
0
0
17,013
0
0
0
14,529
8,200
6,400
4,400
8,491
1,990
9,200
10,700
12,429
800
1,121
1,400
2,415
1,155
1,139
1,134
868
1,088
1,269
1,268
1,269
1,269
1,269
1,268
2,056
1,992
1,997
9,950
11,207
11,2079,9501,9971,9922,0561,2681,2691,2691,2691,2681,2691,0888681,1341,1391,1552,4151,4001,12180012,42910,7009,2001,9908,4914,4006,4008,20014,52900017,0130002,6490000000000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
20,071
8,200
6,400
4,400
1,429
1,990
1,400
1,400
1,429
800
1,200
1,400
1,310
0
0
0
0
0
0
0
0
0
0
0
0
0
0
8,000
0
08,000000000000000001,3101,4001,2008001,4291,4001,4001,9901,4294,4006,4008,20020,071000000000000000000000000000
       Accounts payable 
0
0
0
8,435
0
0
0
4,857
0
0
0
5,875
0
0
0
4,268
0
0
0
15,305
0
0
0
3,868
0
0
0
5,320
0
0
0
3,112
0
0
0
3,167
0
0
0
4,772
3,128
13,408
3,441
3,760
3,216
3,991
3,539
2,860
3,519
4,931
6,320
16,303
12,108
5,864
6,069
9,029
9,0296,0695,86412,10816,3036,3204,9313,5192,8603,5393,9913,2163,7603,44113,4083,1284,7720003,1670003,1120005,3200003,86800015,3050004,2680005,8750004,8570008,435000
       Other Current Liabilities 
0
0
0
7,691
13,037
16,878
16,321
16,609
37,304
18,762
12,575
15,650
16,682
12,674
11,560
14,898
20,329
36,212
51,714
41,644
64,906
61,525
51,416
25,164
47,916
45,676
46,916
16,550
36,609
22,389
18,184
5,812
20,941
13,943
12,679
9,325
25,810
19,646
18,076
18,233
35,637
40,378
39,709
42,104
49,903
36,816
39,584
26,796
25,553
27,574
12,506
24,883
20,108
2,167
1,803
-4,726
-4,7261,8032,16720,10824,88312,50627,57425,55326,79639,58436,81649,90342,10439,70940,37835,63718,23318,07619,64625,8109,32512,67913,94320,9415,81218,18422,38936,60916,55046,91645,67647,91625,16451,41661,52564,90641,64451,71436,21220,32914,89811,56012,67416,68215,65012,57518,76237,30416,60916,32116,87813,0377,691000
   > Long-term Liabilities 
0
0
0
434
414
402
775
536
541
389
827
480
489
500
526
403
537
0
1,435
3,859
515
10,074
8,884
7,639
10,413
9,856
9,953
5,626
3,446
2,441
1,905
1,570
1,190
952
954
595
2,480
1,865
1,257
766
702
430
156
140
1,572
1,718
1,421
12,090
11,139
11,326
10,725
11,073
15,595
14,006
17,280
11,100
11,10017,28014,00615,59511,07310,72511,32611,13912,0901,4211,7181,5721401564307027661,2571,8652,4805959549521,1901,5701,9052,4413,4465,6269,9539,85610,4137,6398,88410,0745153,8591,4350537403526500489480827389541536775402414434000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
156
140
1,572
1,719
1,421
2,041
1,749
1,749
1,749
4,164
6,057
4,902
0
0
004,9026,0574,1641,7491,7491,7492,0411,4211,7191,572140156000000000000000000000000000000000000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
84
2,646
2,241
1,905
22
0
952
0
0
0
-1
0
-1
0
0
0
1,174
0
-1
0
10,049
9,390
9,577
8,976
6,909
0
9,104
0
0
009,10406,9098,9769,5779,39010,0490-101,174000-10-10009520221,9052,2412,64684000000000000000000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
17,729
0
0
0
11,775
0
0
0
8,547
0
0
0
7,169
6,852
6,562
6,930
7,263
8,051
9,178
10,028
11,635
12,537
13,565
14,356
15,047
0
20,323
0
0
0020,323015,04714,35613,56512,53711,63510,0289,1788,0517,2636,9306,5626,8527,1690008,54700011,77500017,729000000000000000000000000000
> Total Stockholder Equity
0
0
0
66,948
62,011
50,133
41,182
29,031
25,963
29,418
33,086
31,187
29,178
26,365
24,010
17,211
19,432
21,019
23,072
19,347
19,600
19,598
14,495
12,363
8,903
5,653
4,199
5,222
2,687
21,588
17,632
15,555
11,848
7,200
6,146
2,181
4,558
13,889
10,547
8,754
9,857
16,465
17,650
19,678
21,880
24,888
27,621
29,444
31,154
35,084
35,326
35,435
35,805
31,567
20,393
17,305
17,30520,39331,56735,80535,43535,32635,08431,15429,44427,62124,88821,88019,67817,65016,4659,8578,75410,54713,8894,5582,1816,1467,20011,84815,55517,63221,5882,6875,2224,1995,6538,90312,36314,49519,59819,60019,34723,07221,01919,43217,21124,01026,36529,17831,18733,08629,41825,96329,03141,18250,13362,01166,948000
   Common Stock
0
0
0
103,541
0
0
0
30,000
0
0
0
30,000
0
0
0
30,000
0
0
0
30,080
0
0
0
30,080
0
0
0
14,534
2,687
21,588
17,632
21,801
11,848
7,200
6,146
10,901
4,558
13,889
10,547
15,508
9,857
16,465
17,650
15,508
21,880
24,888
27,621
15,508
31,154
35,084
35,326
15,508
35,805
31,567
20,393
0
020,39331,56735,80515,50835,32635,08431,15415,50827,62124,88821,88015,50817,65016,4659,85715,50810,54713,8894,55810,9016,1467,20011,84821,80117,63221,5882,68714,53400030,08000030,08000030,00000030,00000030,000000103,541000
   Retained Earnings Total Equity00000000000000000000000000000000000000000000000000000000
   Accumulated Other Comprehensive Income 00000000000000000000000000000000000000000000000000000000
   Capital Surplus 00000000000000000000000000000000000000000000000000000000
   Treasury Stock00000000000000000000000000000000000000000000000000000000
   Other Stockholders Equity 
0
0
0
209,559
0
0
0
40,240
0
0
0
40,176
0
0
0
40,244
0
0
0
536
0
0
0
642
0
0
0
580
0
0
0
15,251
0
0
0
15,268
0
0
0
33,240
9,857
16,465
17,650
32,831
21,880
24,888
27,621
33,386
31,154
35,084
35,326
33,485
35,805
31,567
0
0
0031,56735,80533,48535,32635,08431,15433,38627,62124,88821,88032,83117,65016,4659,85733,24000015,26800015,25100058000064200053600040,24400040,17600040,240000209,559000



Balance Sheet

All numbers in thousands.




Cash Flow

Currency in SEK. All numbers in thousands.




Income Statement

Currency in SEK. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue84,678
Cost of Revenue-53,240
Gross Profit31,43831,438
 
Operating Income (+$)
Gross Profit31,438
Operating Expense-47,239
Operating Income-15,801-15,801
 
Operating Expense (+$)
Research Development9,539
Selling General Administrative44,381
Selling And Marketing Expenses0
Operating Expense47,23953,920
 
Net Interest Income (+$)
Interest Income0
Interest Expense-578
Other Finance Cost-375
Net Interest Income-203
 
Pretax Income (+$)
Operating Income-15,801
Net Interest Income-203
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-18,190-13,412
EBIT - interestExpense = -16,379
-18,190
-17,667
Interest Expense578
Earnings Before Interest and Taxes (EBIT)-15,801-17,612
Earnings Before Interest and Taxes (EBITDA)-10,049
 
After tax Income (+$)
Income Before Tax-18,190
Tax Provision-146
Net Income From Continuing Ops-15,265-18,336
Net Income-18,245
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses100,479
Total Other Income/Expenses Net-2,389203
 

Technical Analysis of Ortivus
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Ortivus. The general trend of Ortivus is BEARISH with 85.7% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Ortivus's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-85.7%) Bearish trend (85.7%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Ortivus AB ser. B.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 3.6 < 3.73 < 3.8.

The bearish price targets are: 2.59 > 2.53 > 2.15.

Tweet this
Ortivus AB ser. B Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Ortivus AB ser. B. The current mas is .

The long score for the Moving Averages is 1/14.
The longshort score for the Moving Averages is -12/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Ortivus AB ser. B Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Ortivus AB ser. B. The current macd is -0.08834136.

The long score for the Moving Average Convergence/Divergence (MACD) is 2/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 0/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Ortivus price going up in the near term. +2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Ortivus. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Ortivus price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Ortivus AB ser. B Daily Moving Average Convergence/Divergence (MACD) ChartOrtivus AB ser. B Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Ortivus AB ser. B. The current adx is 31.92.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -3/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Ortivus shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX > 25 && ADX trending down: The ADX is above 25 and indicates a strong bearish trend. The ADX is declining, the bearish trend is weakening. Could be a potential reversal to the upside. -2
Ortivus AB ser. B Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Ortivus AB ser. B. The current sar is 3.35330782.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Ortivus AB ser. B Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Ortivus AB ser. B. The current rsi is 42.26. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending down: The RSI is trending down. -1
Ortivus AB ser. B Daily Relative Strength Index (RSI) ChartOrtivus AB ser. B Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Ortivus AB ser. B. The current phase is Continuation in bear market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -4/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Ortivus price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Ortivus AB ser. B Daily Stochastic Oscillator ChartOrtivus AB ser. B Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Ortivus AB ser. B. The current cci is -57.47938751.

Ortivus AB ser. B Daily Commodity Channel Index (CCI) ChartOrtivus AB ser. B Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Ortivus AB ser. B. The current cmo is -16.90541708.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Ortivus AB ser. B Daily Chande Momentum Oscillator (CMO) ChartOrtivus AB ser. B Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Ortivus AB ser. B. The current willr is -57.89473684.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Ortivus is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Ortivus AB ser. B Daily Williams %R ChartOrtivus AB ser. B Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Ortivus AB ser. B.

Ortivus AB ser. B Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Ortivus AB ser. B. The current atr is 0.26537795.

Ortivus AB ser. B Daily Average True Range (ATR) ChartOrtivus AB ser. B Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Ortivus AB ser. B. The current obv is -457,332.

Ortivus AB ser. B Daily On-Balance Volume (OBV) ChartOrtivus AB ser. B Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Ortivus AB ser. B. The current mfi is 65.91.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Ortivus AB ser. B Daily Money Flow Index (MFI) ChartOrtivus AB ser. B Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Ortivus AB ser. B.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-08STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-09CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-11-13STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-14DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-11-15MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2023-11-20WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-11-21SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-11-22BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2023-11-24BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2023-11-29STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-11-30RSI SHORT ENTRY LONG CLOSE70 crossover to downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-01ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-04STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-06RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-07STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-08RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-13MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2023-12-15SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-19MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2023-12-20MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-21STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-27STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-29DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-01-02DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-01-03STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-04WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-09DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-10SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-11STOCH SHORT EXITThe %K line crosses above the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-15STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-17WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-18MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-23MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-25DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-26MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-01-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-02STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-06STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-07STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-09MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-12DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-13WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-14STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-16CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-20STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-02-21CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-22SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-26MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-02-28WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-29MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-01CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-04STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-06STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-08CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-13STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-14CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-18SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-20STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-25STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-26MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-28STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside

6.3. Candlestick Patterns

Ortivus AB ser. B Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Ortivus AB ser. B based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5042.265
Ma 20Greater thanMa 503.052
Ma 50Greater thanMa 1003.287
Ma 100Greater thanMa 2003.304
OpenGreater thanClose3.010
Total1/5 (20.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Ortivus with someone you think should read this too:
  • Are you bullish or bearish on Ortivus? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Ortivus? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Ortivus AB ser. B

I send you an email if I find something interesting about Ortivus AB ser. B.


Comments

How you think about this?

Leave a comment

Stay informed about Ortivus AB ser. B.

Receive notifications about Ortivus AB ser. B in your mailbox!